| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K97651142 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | lomeguatrib | CTRPv2 | pan-cancer | AAC | 0.035 | 0.4 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.25 | 0.4 |
| mRNA | GW843682X | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | neratinib | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.051 | 0.4 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.4 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.043 | 0.4 |
| mRNA | GSK2636771 | CTRPv2 | pan-cancer | AAC | 0.04 | 0.4 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.063 | 0.4 |